Filing metadata

Accession number
0001479290-21-000070
Form type
Form 3
Filer
Revance Therapeutics, Inc.
CIK
CIK 1479290
Filed
Mar 10, 2021
Reporting period
Mar 06, 2021
Description
Initial ownership

Explore SEC Filings Hub